Heterogeneous surface-modified nanoplatforms for the targeted therapy of haematological malignancies.
Sign Up to like & getrecommendations! Published in 2019 at "Drug discovery today"
DOI: 10.1016/j.drudis.2019.10.001
Abstract: Here, we focus on nanoparticle (NP)-based platforms for the targeted therapy of haematological malignancies (HMs), providing an overview of surface-modified nanoplatforms, such as aptamer-, metal-, nucleic acid-, toxin, and peptide-modified NPs, for the efficient targeting… read more here.
Keywords: surface modified; targeted therapy; therapy haematological; haematological malignancies ... See more keywords